The first patient in the UK has been treated by the NHS with CSL Behring’s haemophilia B gene therapy Hemgenix (etranacogene ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) to treat bullous ...

Instead, identifying early-stage individuals necessitates biomarker-based screening, which adds layers of complexity to an ...

Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, ...

Ventyx Biosciences has shared promising top-line results from a phase 2a study of its investigational central nervous system ...

Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...

While AI’s influence is growing across drug discovery, clinical trials and supply chains, it doesn’t provide that ...

Imagine MedEd that thinks, adapts, and delivers unprecedented insights. Better yet, experience if for yourself in our ...

The use of AI in pharma can expedite drug development and manufacturing, enabling novel medicines to get to underserved ...

Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

In today’s fast-paced experience economy, pharma companies can no longer rely on static displays and outdated engagement ...

Last month, the ISPOR annual meeting in Montreal was brimming with opportunities to explore the latest developments and ...